Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10015 Clinical Development of Stem Cell Therapies: Scientific, Regulatory and Ethical Considerations
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
Clinical Development of Stem Cell Therapies: Scientific, Regulatory and Ethical Considerations


Date(s) And Time(s):
Apr 12 2010 8:00AM - Apr 13 2010 1:00PM

Location:
Bethesda North Marriott Hotel and Conference Center
5701 Marinelli Road
North Bethesda, MD 20852 

Interest Area(s):
CMC,Clinical Safety/Pharmacovigilance,Clinical Research,Nonclinical,Research & Development

Overview:

Strategies for Enabling the Clinical Development of Stem Cell Products.

Join representatives from academia, industry and regulatory agencies, to analyze the transitional process from discovery and regulatory approval to the therapeutic use of stem cell products. Experts will present specific examples of, and solutions for, issues related to the preclinical, CMC, and clinical stages of development for stem cell products

Featured Topics
• FDA and EMEA experiences with clinical development of stem cells
• CMC: Addressing the issues of reagents, devices and potency
• Preclinical and clinical issues in the development of stem cells for therapeutic use
• NIH Guidelines
• Examples of ASC, ESC and iPC cells in preclinical/clinical development
• Immunosuppression strategies



Learning Objectives:
At the conclusion of this conference, participants should be able to:
• Discuss US and EU regulatory requirements for stem cell products
• Outline strategies for clinical development of stem cell products
• Describe the ethical challenges surrounding stem cell research
• Compare successful product development strategies from industry case studies
• Explain CMC challenges of reagents, devices and potency


Target Audience:
Professionals involved in the development and regulation of stem cells for therapeutic use, including those involved in:
• Biotechnology
• Clinical research and development
• Clinical safety/Pharmacoepidemiology/Pharmacovigilance
• Chemistry, Manufacturing and Controls (CMC)
• • Devices
• • Nonclinical safety and efficacy/Toxicology
• • Quality control/assurance
• • Regulatory affairs/Policy/Drug or device approval/GRP
• • Research and development/Strategic issues
• • Preclinical studies
• • Clinical trials



Event Code:
10015

Contact Information:
EVENT INFORMATION
Contact Marjorie Davis, Program Developer, Phone +1.215.442.6176
Fax +1.215.442.6199, email
Marjorie.Davis@diahome.org